Interferon regulates expression of mda-6/WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 murine melanoma cells

被引:14
作者
Arany, I [1 ]
Fleischmann, CM [1 ]
Tyring, SK [1 ]
Fleischmann, WR [1 ]
机构
[1] UNIV TEXAS, MED BRANCH, DEPT DERMATOL, GALVESTON, TX 77555 USA
关键词
LEUKEMIA-CELLS; DIFFERENTIATION; POTENTIATION; INDUCTION; GAMMA; MICE;
D O I
10.1006/bbrc.1997.6516
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) induce growth arrest and terminal differentiation through regulation of proliferative genes in a variety of cell types including tumor cells, Growth of melanoma cells is believed to be controlled by the cyclin-dependent kinase inhibitor, mda-6/WAF1/CIP1 gene, IFNs affect the expression of WAF1 in several cell types, including human melanomas. In our earlier reports we demonstrated the antitumor and anticellular activities of different IPN-types on B16 murine melanoma cells. The present study aimed to demonstrate the involvement of mda-6/WAF1 and related cyclin-dependent kinases in antitumor action of different IFN-types in B16 melanoma cells. IFN-alpha has been proven to be a potent inducer of mda-6/WAF1, also inhibiting cyclin-dependent kinases, such as cdc2- and cdk2-kinase. This induction is p53-independent. However, IFN-gamma affects B16 cells differently, it induces p53 activity without inducing WAF1. The combination of IFN-alpha plus IFN-gamma is additive rather than synergistic. Our data demonstrate differential effects of different IFNs on murine B16 melanoma cells which may have relevance in nonsurgical treatment of melanomas. (C) 1997 Academic Press.
引用
收藏
页码:678 / 680
页数:3
相关论文
共 14 条
[1]  
ALBINO AP, 1992, PIGM CELL RES, P199
[2]  
Arany I, 1996, IN VIVO, V10, P119
[3]   INTERFERON TREATMENT ENHANCES THE EXPRESSION OF UNDERPHOSPHORYLATED (BIOLOGICALLY-ACTIVE) RETINOBLASTOMA PROTEIN IN HUMAN PAPILLOMA VIRUS-INFECTED CELLS THROUGH THE INHIBITORY TGF-BETA-1/IFN-BETA CYTOKINE PATHWAY [J].
ARANY, I ;
RADY, P ;
TYRING, SK .
ANTIVIRAL RESEARCH, 1994, 23 (02) :131-141
[4]   TRANSCRIPTION FACTORS IN INTERFERON SIGNALING [J].
DAVID, M .
PHARMACOLOGY & THERAPEUTICS, 1995, 65 (02) :149-161
[5]  
FLEISCHMANN WR, 1982, CANCER RES, V42, P869
[6]  
GUDAS J, 1995, ONCOGENE, V11, P253
[7]  
JIANG HP, 1994, ONCOGENE, V9, P3397
[8]  
JIANG HP, 1995, ONCOGENE, V10, P1855
[9]   Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].
Kirkwood, JM ;
Strawderman, MH ;
Ernstoff, MS ;
Smith, TJ ;
Borden, EC ;
Blum, RH .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17
[10]   CIRCADIAN DEPENDENCE OF INTERFERON ANTITUMOR-ACTIVITY IN MICE [J].
KOREN, S ;
WHORTON, EB ;
FLEISCHMANN, WR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (23) :1927-1932